The Ethical Conundrums of MAiD
Saturday, May 4, 2024 |
10:45 AM - 11:30 AM |
Speaker(s)
Andrea Frolic and Tim Holland
Session Details
At the end of this session, participants will be able to:
- Identify and analyze the complex ethical dilemmas that arise in MAiD cases and demonstrate an understanding of the shifting ethical landscape.
- Evaluate the potential implications of evolving ethical considerations on MAiD legislation and healthcare practices, and engage in thoughtful and constructive conversations on the subject, taking into account a broad range of perspectives and moral frameworks
- Discuss the importance of having a reasoned approach to ethical dilemmas and why we ought to avoid intuition or ""gut instinct"" in our moral assessments
Speaker
Dr. Andrea Frolic
Director, MAiD
Hamilton Health Sciences
Panelist
Biography
Andrea is the Director of the Program for Ethics and Care Ecologies (PEaCE) at Hamilton Health Sciences and Assistant Professor in the Department of Family Medicine at McMaster University. She has a Ph.D. in cultural Anthropology from Rice University in Houston, Texas, including a two-year fellowship in Clinical Ethics at the University of Texas, MD Anderson Cancer Center. By sparking collaboration between psycho-spiritual care, ethics, trauma-informed care and end-of-life initiatives, including Medical Assistance in Dying (MAiD), the innovative PEaCE program aims to enhance provider resilience, teamwork, ethical practice, and quality of living and dying. Andrea’s research interests include: MAiD patient/family experiences and quality improvement; healthcare worker well-being; ethics integration from bedside-to-boardroom; and developing practices to enable whole person care for patients, families and providers.
I have/had an affiliation (financial or otherwise) with a for-profit or not-for-profit organization.
- Received payment from an organization: Hamilton Health Sciences (Director, Ethics and MAiD program)
- Received a grant or honorarium: CAMAP (Member of Canadian MAiD Curriculum Development Committee)
I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e., "off-label" use of medications)
I have/had an affiliation (financial or otherwise) with a for-profit or not-for-profit organization.
- Received payment from an organization: Hamilton Health Sciences (Director, Ethics and MAiD program)
- Received a grant or honorarium: CAMAP (Member of Canadian MAiD Curriculum Development Committee)
I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e., "off-label" use of medications)
Dr. Timothy Holland
Deptartment Head
Bioethics, Dalhousie University